Medical cannabis reform is at a critical juncture in Australia. The TGA (Therapeutic Goods Administration) recently finalised its open submission, posing 29 pivotal questions that will shape the future of access, quality, and patient care.In this episode, Chad details OnTracka's official submission in the interest of transparency. We reveal our data-driven responses to these crucial questions, covering major topics that will define the industry's direction for years to come.Join us to understand the arguments currently shaping medical cannabis policy.

What happens when you take an extended break from THC? In this episode, Chad shares his personal 30-day reset experience, comparing CBD (60–80mg) with prior THC use and reflecting on what’s changed since he started doing these annual resets back in 2018.We cover:Symptom relief on CBD vs THCLonger onset and therapeutic window with CBDReduced cravings and stress spikes compared to earlier breaksObserved differences in muscle soreness, sleep, and recoveryA hypothesis around THC’s role in rest, repair, and parasympathetic activityLessons for patients, clinicians, and anyone curious about cannabinoid use⚠️ This is not medical advice. These are individual learnings shared to help spark conversation and support evidence-based discussion.👉 Watch until the end for Chad’s conclusion on why he’ll continue CBD instead of returning to THC for now.Subscribe to stay updated on conversations that inspire higher living, deeper health, and conscious transformation.

Episode 50 is here, and we're discussing this one into the latest AHPRA guidelines on medical cannabis in Australia. 🤔 This has been an ongoing conversation in the industry, with concerns raised around prescribing practices, data transparency, and patient safety.We break down what these new restrictions mean for prescribers and challenge the call for more data from the regulator itself. We also tackle the sometimes contentious topic of cannabis dependence and addiction, advocating for a balanced, evidence-based approach to patient care.Join us as we explore why leading with data is crucial for the future of medical cannabis in healthcare, and why clinics with robust systems should be stepping up to lead the way. Interested in learning more about OnTracka?EMAIL: info@ontracka.comINSTAGRAM: @OnTrackaAppX/TWITTER: @OnTrackaAppDownload the OnTracka app:AppleGoogle Play#ahpra #MedicalCannabis #Australia #healthcarebusiness

In this episode of Higher Living, Chad dives into the rising buzz around clinics in Australia’s changing healthcare space. It’s been a big week of news, with Incannex Healthcare announcing a joint venture with Mind Medicine Australia, and Emyria landing a funding deal with Medibank. Clinics are back in the spotlight. But if they’re not turning a profit, why is everyone so eager to build or support them?

From CDA Clinics and Montu to Eucalyptus and their proprietary tech, we take a closer look at what’s really driving the boom. Is it the prescriptions? The patient services? Or is it all about the strategy?

Chad also breaks down two key models of vertical integration: owning the medications, or partnering with multiple suppliers. Each approach has major implications for patient access and long-term clinic sustainability.

So, is there actually money in clinics or are we missing something bigger?

What if everything you thought about health was missing one key ingredient?In this episode, Chad sits down with Jodi Duval, a naturopath, clinical educator, and leader in integrative medicine for a deep dive into the emerging science behind personalised wellness, preventative care, and what it really means to shift the needle on health.From cannabinoids to mitochondria, spirituality to science, and everything in between, this conversation opens doors to a whole new way of thinking about longevity, energy, and healing.Guest: Jodi Duval – Founder of Revital Health

Tegan Scates, the founder of Bloomly, is back and better than ever! They discuss the importance of women in the cannabis industry, the need for personalised treatment plans, and the potential of different consumption methods. Tegan shares her insights on the challenges and opportunities in the industry and her vision for a more inclusive and patient-centered approach to medical cannabis.

In this episode, Chad discuss the recent tragic death of a patient and the implications for the future of the cannabis industry in Australia. He explores the importance of transparency, regulation, and ethical practices to ensure the safety and well-being of patients. This episode is sensitive in nature and discusses a tragic event. Viewer discretion is advised

In this episode, guest Harry shared his experience in the cannabis industry and how the cannabis consumption landscape is not only changing-from concentrates being on the rise to personalized approaches.